<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Evry_Modeling skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Evry/Modeling</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><NAV class="navbar navbar-default navbar-fixed-top" role="navigation" style="margin-top:16px"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#main-navbar-collapse"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="main-navbar-collapse"><UL class="nav navbar-nav"><LI><A href="https://2015.igem.org/Team:Evry">Home</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown">Project </A></LI><LI><A href="https://2015.igem.org/Team:Evry/Project/Induction">Induction</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Project/Repression">Repression</A></LI></UL><LI><A href="https://2015.igem.org/Team:Evry/Parts">Parts</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Modeling">Machine learning</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Practices">Human practices</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Notebook">Notebook</A></LI><LI class="dropdown"><A href="#" data-toggle="dropdown">Team </A></LI><LI><A href="https://2015.igem.org/Team:Evry/Team">Our team</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Attributions">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:Example/Acknowledgements">Acknowledgements</A></LI><LI><A href="https://2015.igem.org/Team:Evry/Sponsors">Sponsors</A></LI><UL class="nav navbar-nav navbar-right"><LI><A href="https://twitter.com/iGEM_Evry_2015" target="_blank" title="Follow us on Twitter!"> @iGEM_Evry_2015</A></LI></UL></DIV></DIV></NAV><DIV class="container"><DIV class="page-header"><H1>Machine learning</H1></DIV><P class="lead text-justify">We are currently working on a machine learning approach, in order to predict which antigen will be presented efficiently to the MHC-I and MHC-II.</P><P class="text-justify">We plan to create a pipeline allowing us to select the best candidate tumoral antigen to use for a vaccine. We already have a few ideas on criterias that could be used to choose such an antigen: </P><UL><LI>Antigens of oncolytic viruses (HPV for instance) can be tumor-specific. </LI><LI>The antigen can be a mutated version of a gene that is found in healthy tissue: for instance, a mutated p53 gene. </LI><LI>Testis-like antigens (normally found in gonad) can be expressed by a tumor because they are growth factors. However, using this type of antigens could have side effects on the gonad: evaluating if it is worth it to take such a risk would therefore be needed.</LI></UL><P class="text-justify">Once we are able to determine the most relevant targets, we won't express the whole corresponding proteins. We only need to express short fragments of them, corresponding to putative cleavage sites by the proteasome to link to MHC-I and MHC-II. Some tools are available to predict those sites, even if their accuracy is far from optimal. Those predictions could also be improved. </P></DIV><DIV id="toTop"><SPAN class="scrolltext">To top</SPAN></DIV></DIV></DIV></DIV></DIV></BODY></HTML>